Figure 5

Luteal support Bayesian fixed effect consistency forest plot (Odds ratio, 95% CrI) for Clinical Pregnancy (A) Live Birth (B) Biochemical Pregnancy (C) Miscarriage (D) and Multiple pregnancy (E) OHSS (F) outcomes). Graph generated by MetaInsight R package. Tabular results of design-by-treatment interaction model consistency depicted in Table S1–S2 per outcome. Node splitting model per comparison (direct and indirect effects) depicted in Table S.6–7. placebo (no exposure), SCP (Subcutaneous progesterone), VP (vaginal progesterone), IMP + VP (intramuscular progesterone and vaginal progesterone), VP + OE (vaginal progesterone and oral estradiol), IMP (intramuscular progesterone), VP + PatchE (vaginal progesterone and patch oestrogen), IMP + OE (intramuscular progesterone and oral estradiol), IMHCG (intramuscular hCG), SCP + VP, Intranasal GnRH-a, OP (oral progesterone), IMP + IME (intramuscular progesterone and intramuscular estradiol), IMP + VP + OE (Intramuscular progesterone, vaginal progesterone and oral estradiol), IMP + VE (Intramuscular progesterone and vaginal estradiol), VP + SCGNRH-a [(Vaginal progesterone and subcutaneous GNRH agonist (GNRH-a)], VP + OE + SCGNRH-a (Vaginal progesterone, oral estradiol and subcutaneous GNRH-a), RP (Rectal progesterone), SCHCG (subcutaneous HCG), VP + DHEA (vaginal progesterone and oral DHEA), IMP + VP + SCGNRH-a (Intramuscular progesterone, vaginal progesterone and subcutaneous GNRH-a), OP + VP (oral progesterone and vaginal progesterone).